In the late summer of 1949 cases of what was generally assumed to be abortive or non-paralytic poliomyelitis occurred in and around Worcester, Massachusetts. In cooperation with the Division of Communicable Diseases of the Health Department of the Commonwealth of Massachusetts, epidemiological and laboratory studies were initiated in an effort to determine more precisely the etiology of the disease. The recent investigations of Dalldod (1) and of Melnick (2--4) and their collaborators have resulted in the isolation of numerous virus strains from patients suffering from illnesses resembling abortive poliomyelitis in various parts of the country. These agents are characterized by their limited pathogenicity for laboratory animals, since suckling mice and hamsters and immature cynomolgus monkeys (5) are the only species proven to be susceptible so far. Most of the strains produce lesions in the skeletal musculature, leaving the CNS and other viscera unscathed. With other strains, lesions involving the brain and the myocardium and other visceral organs have been mentioned, though not described in detail. Serological evidence suggests the existence of at least several apparently distinct types (6-8). Since the clinical features of the Worcester cases resembled those exhibited by the patients from whom Dalldorf et al.
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VIRAL AGENT I~ROM NON-PARALYTIC POLIOMYELITIS

Source of the Virus
During the month of September, 1949, approximately 30 patients admitted to the Belmont Hospital, Worcester, Massachusetts, with the diagnosis of non-paralytic poliomyelitis were studied. Although all cases came from Worcester or its neighboring communities, epidemiological investigations failed to reveal any demonstrable connection between the individual cases. The characteristic symptoms were headache, fever, and lassitude of several days' duration, together with complaints of a stiff neck. Physical examination revealed no muscle weakness, but in some cases signs of mild meningeal irritation were observed. The results of various laboratory examinations were essentially normal with one consistent exception; the spinal fluid showed a mild pleocytosis (I00 to 200 cells per c. ram.) which was essentially lymphocytic in nature. Recovery was prompt, uncomplicated, and uneventful and no residual muscle weakness was noted. Stool specimens obtained as soon as possible after admission were secured from each patient. Blood specimens in the acute and convalescent phases were also collected for serological studies.
From the stool of one patient (Powers) a viral agent was isolated, and the clinical history of this case is given in more detail. An agent was also isolated from the stool of another patient (Matulaitis) hospitalized in the same period because of a similar syndrome. We have only recently been able to propagate it in series, and further work must be carried out before it can be identified. It is interesting to note that during this same period numerous cases of clinically typical poliomyelitis with definite paralysis were admitted to the hospital. Materials for laboratory studies were not obtained from these cases.
Case H/~tory.--Powers, an 8 year old white girl was admitted because of headache of 4 days' duration, accompanied by nausea, sore throat, and pain in the back of the neck for 24 hours prior to admission. Some degree of fever had been present. Her past history was noncontributory. Physical examination revealed a mildly ill child in no distress. The temperature was 100.4°F., pulse 110, and respirations 24. Abnormal physical findings were limited to slight injection of the pharynx and interscapular pain on anterior flexion of the neck. Laboratory data included a slight anemia (3.9 million RBC per c. ram. Polymorphonueiears, 53, lymphocytes, 41, monocytes, 4, eosinophfls, 2). Urine analysis was essentially normal and no pathogenic organisms were found in a throat culture. Lumbar puncture on the day following admission yielded clear, colorless spinal fluid with a white cell count of 85 per c. ram. 99 per cent of the cells observed were described as lymphocytes. No bacterial organisms were demonstrated by smear or culture. The patient was treated symptomatically, and she became afebrile the day after admission. No spasm or weakness of any muscle group was recognized. She was discharged asymptomatic on the 15th hospital day with a diagnosis of poliomyelitis, non-paralytic. When examined a month later no evidence of muscle weakness could be detected.
Materials and Methods
Stool specimens were obtained as soon as possible after admission. These were stored in the refrigerator at 4°C. until they could be brought to the laboratory--usually a matter of several days. The fecal material was then frozen in its original state or as a 20 per cent emulsion and stored in a C02 cabinet at -70°C. until the time of inoculation.
Blood was drawn from each patient as soon as possible after admission, and again at time of discharge--usually about 2 weeks later. In the case of Powers a third specimen was drawn a month after her admission to the hospital Late convalescent bloods were likewise obtained from several other patients. These specimens reached the laboratory as clotted blood or as serum. The serum was pipetted off after centrifugation and stored at -20°C. The preparation of fecal specimens for inoculation followed in general the technique outlined by Melnick el al. (2) (3) (4) . A 20 per cent suspension in saline was made by grinding the fecal material with mortar and pestle. The suspension was then spun at 3,000 a.P.~, in a horizontal centrifuge. The superuatant fluid was pipetted off and centrifuged in an angle head at 18,000 R.P.~. for 30 minutes at 2-4°C. The supernatant was removed and to it was added penicillin and streptomycin to make a final concentration of 1000 units and 1000 micrograms per ml. respectively. One litter of mice not older than 48 hours was inoculated with each specimen by the intraperitoneal route. The size of the inoculum was 0.01 to 0.02 ml. Mice were observed for 3 weeks before being discarded as negative. At least one blind passage, harvesting brain or carcass, was made with each negative specimen and from nearly every Utter at least one mouse was sacrificed for pathological examination.
Experimental Observations
One stool specimen from each of 19 patients with the diagnosis of nonparalytic poliomyelitis was studied. In 17 instances no virus was isolated. From two specimens (patients Powers and Matulaitis) viruses were isolated. In the first case, from the stool specimen obtained during the acute phase of the disease (5 days after onset of symptoms), a viral agent was isolated which produced obvious signs of illness in infant mice followed by death. The lesions included myocarditis, adipositis, inflammatory and degenerative lesions in the brain, and pancreatitis. These lesions are described in detail in the accompanying paper (9) . No lesions involving the skeletal musculature have been found to date. Their absence stands in contrast to the findings reported by Dalldorf et al. (1, 6) and by Melnick et al. (2) (3) (4) . No difficulty was experienced in establishing the virus in mice. A sharp age susceptibility was noted however. Attempts to isolate the agent from a second stool specimen brought in 1 month after the patient's discharge from the hospital failed.
In the second case, Matulaitis, a viral agent was isolated from the stool specimen obtained 1 day after admission to the hospital (again 5 days after the onset of clinical symptoms). Its biological characteristics have not been studied in detail. This agent causes lesions of the heart, brain, and fat, as well as myositis but as yet no lesions have been found in the liver or pancreas (9) .
Incubation Period.raThe first litter was inoculated when 1 day old with a 20 per cent stool suspension from Powers by the intraperitoneal route. These mice remained well until the morning of the 6th day at which time one was discovered in a moribund state, while a second animal showed gross tremors of the extremities. Both were sacrificed to secure material for passage. The remainder of the litter remained well during 4 weeks. Subsequent passages have been accompanied by a gradual shortening of the incubation period. By the tenth passage it had become constant averaging 2 to 3 days.
The first signs of illness were usually slight tremors of the extremities, which became more pronounced until the entire animal appeared to shake as it attempted to raise itself or to move around. Accompanying the tremors were weakness, cyanosis and gasping respiration, and frequently retardation of growth. Death usually ensued within 48 hours of the development of signs but occasional animals survived for several days longer. Although apparent paralysis Of the extremities has been observed it has not been a frequent finding. Mice surviving the inoculation of higher dilutions of virus sometimes appeared stunted, and showed transient incoordination.
Route of Inoculation.--Although the intraperitoneal method of inoculation has been our standard procedure a few animals have been inoculated by the intracerebral route. These mice---4 and 5 days old at the time of inoculation 0/s 0/9 0/9 0/9 --developed typical signs 72 hours later. They were sacrificed when moribund in order to obtain material for pathological examination. The lesions observed did not differ essentially from those found after intraperitoneal inoculation, except for the more frequent occurrence of liquefaction necrosis of the brain.
Age Susceptibility.--Both DaUdorf el al. (1) and Melnick et al. (2) have pointed out the marked correlation between the age of the animal and its susceptibility. Our agent differs somewhat from the Coxsackie group of viruses in this respect inasmuch as we have had no consistent success in producing lethal infections in mice by the intraperitoneal route after the 3rd day of life. The results of a typical experiment are given in Table I .
Older mice (7 to 22 days) inoculated by several routes (intraperitoneal, intramuscular, intracerebral) have failed to develop signs of infection, although CNS lesions and adipositis have been noted on pathological examination in some instances.
Resistance of Virus to Pkysical and Chemical
Agents.--Observations on the resistance of the virus to physical and chemical agents are limited. It has been stored for 3 months at --70°C. without obvious loss of activity. It survives at least 12 hours at 4°C., and for at least an hour at room temperature. After 18 hours' exposure to a saturated solution of ether at 4°C. the virus was still infectious.
Bacterial C¢tltures.--Repeated attempts to isolate a bacterial agent from infected material have been unsuccessful. The media routinely employed included blood agar plates and tryptic digest broth for aerobic cultures, and thioglycollate broth (and occasionally cooked meat tubes) for anaerobic cultures. Pleuropneumonia-like agents have not been demonstrated using the techniques outlined by Dienes (11) .
Filtration Experiments.raThe agent passed readily through a sintered glass Coming "UF" falter which retained a culture of Bacillus prodigiosus.
Reisolation of the Virus.MTwo months after the first isolation of this virus a second attempt was made to obtain it from the same stool specimen. This had been stored at --70°C. in the form of a 20 per cent saline suspension. Two day old mice inoculated intraperitoncally with the thawed material remained well for 1 week. When, however, they were autopsied at the end of this time typical gross and microscopic pathological lesions were found. Further passage of this material resulted in the development of signs of the disease in 7 of 16 suckling mice inoculated, and the typical gross and microscopic lesions were found.
Localization of Viru~.--The inoculum used in the first five passages consisted of a suspension of ground up brain and cord. In the next five passages brain suspension alone was employed. Mice inoculated with tenth passage material were sacrificed when moribund, the gastrointestinal tract was removed and discarded, and the carcasses ground in phosphate buffer to make a 20 per cent suspension. Penicillin and streptomycin were added to give a final concentration of 2,000 units and 2,000 micrograms per ml., respectively. After light centrifugation the superuatant was removed and used as passage material. Typical gross and microscopic lesions were noted at autopsy of passage mice. Since the titer of virus appeared to be fully as high in carcass as in brain the former has subsequently been used as passage material. The results of titrations obtained with material of two passages are given in Table II . In all titrations the inoculum was 0.02 ml. of tenfold dilutions in isotonic phosphate buffer at pH 7.1 and the route was intraperitoneal.
In one experiment mice were sacrificed when moribund, the interscapular fat was dissected out, pooled, and ground in phosphate buffer to make a I0 per cent suspension. Three day old mice inoculated intraperitoneally with this material sickened and died within 72 hours, and at autopsy typical lesions were observed. No other specific tissues have been examined for the presence of virus, but since heparinized heart's blood was also found to be infective presumably the virus is widely distributed throughout the body.
Host Range.--A litter of day old guinea pigs inoculated by the intracerebral or intraperitoneal route remained well. One day old voles inoculated by the same routes succumbed within 72 hours and virus was demonstrated in their brains by subinoculation into mice. Further serial passages in voles will be required in order to prove that this species is susceptible. A monkey inoculated by the intracerebral route showed no signs of disease and serological studies showed no neutralizing antibody but a greater than 16-fold rise in complement-fixing antibody. Attempts to infect embryonated eggs by various routes have been unsuccessful.
Serological Tests
Methods.--.Preparation of Sera.--Young adult mice were immunized by a series of 3 intramuscular injections of 0.1 to 0.2 ml. of a 40 per cent suspension of infected carcass given at weekly intervals. The animals were bled out 1 to 2 weeks later and the serum was separated, pooled, and stored at -20"C. Normal mice of a comparable age were bled out and the pooled normal serum was stored under similar conditions. A monkey that had survived an intracerebral inoculation of the virus was immunized by a series of intramuscular injections and subsequently bled as an additional source of immune serum.
Preparation of Antigen for Complement
Fixation.--Suckling mice 1 to 2 days of age were inoculated intraperitoneally with a 10 -~ suspension of infected mouse carcass. The animals were sacrificed when moribund approximately 48 hours later. The gastrointestinal tract was dissected out and discarded. The carcasses were then ground in a Waring blendor with 0.85 per cent saline to make a 20 per cent suspension, and stored at -20°C. for2 to 3 days. The suspension was thawed and then centrifuge d for 30 minutes in the horizontal head at 3,000 R.P.~. The supernatant was pipetted off and diluted with an equal amount of 0.85 per cent saline. Ether was added to give a final concentration of 33 per cent by volume, and after a few minutes' careful shaking the resulting mixture was permitted to stand at 4°C. for 16 hours in a separatory funnel. The ether layer was discarded and residual ether was removed from the aqueous phase by means of a vacuum pump. The suspension was then centrifuged at 18,000 R.p.~. for 20 minutes in an angle head at 2°C. and the pellet discarded. The supernatant was frozen and stored at --70°C. until use.
Hemolytic System.--A given volume of a 2 per cent suspension of sheep erythrocytes (washed three times) was mixed with an equal amount of diluted anti-sheep cell rabbit serum containing 2 units of amboceptor and placed in a 37 ° water bath for 10 minutes. These sensitized cells were then used in the test without delay.
Complement.--Sera from 6 to 9 guinea pigs were collected, pooled, and stored in the COs box until use. The complement was always titrated in the presence of the antigen on the morning of each test run.
Titration of Complement Fixation Antigen.--Twofold dilutions of antigen in isotonic veronal
buffer at pH 7.3 were prepared and titrated against twofold dilutions of a hyperimmune mouse serum. The highest dilution of antigen giving complete fixation with 4 units of the antibody was regarded as I antigen unit. The unit of antibody was arbitrarily considered to be the highest dilution of the serum giving complete fixation with the undiluted antigen. In the complement fixation test 8 units of antigen were employed.
Technique of Complement Fixation
Tesl.--The sera inactivated at 560C. for one-half hour were diluted 1:2 to 1:512. To 0.1 ml. of each dilution of serum to be tested 2 units of complement in a volume of 0.1 ml. was added, and finally 0.1 ml. of antigen (containing 8 antigen units). After thorough shaking the tubes were placed in the refrigerator at 4°C. and permitted to stand overnight (approximately 16 hours). The next morning 0.2 ml. of sensitized sheep red blood cells was added to each tube. After incubation for 30 minutes in a water bath at 37°C. the results were read. Complete fixation is recorded as 4+. The end-point selected was the last tube to give to 3+ fixation of complement, Veronal buffer was used as diluent throughout.
Technique of Neutralization Test.--All sera were inactivated by treating at 560C. for 30 minutes just prior to use. In general undiluted and diluted serum was mixed with an arbitrarily selected amount of virus. This was estimated to approximate 100 LD~ or 500 LD~0 per 0.02 ml. (final dilution) but the exact amount varied slightly from one test to another. The titer of the virus was confirmed at the time each test was performed by inoculation of the pertinent dilutions of virus into litters of mice.
Equal amounts (usually 0.15 ml.) of serum (undiluted and diluted 1:5 and 1:50 in phosphate buffer) and of the diluted virus were mixed and permitted to stand at room temperature for 30 minutes. The tubes were then put in an ice water bath and inoculated as soon as possible into suckling mice. For this purpose litters less than 48 hours old were selected and pooled, and the animals distributed at random to minimize the possible effects of individual susceptibility. As a general rule 7 or 8 young were given to each mother, and one group was injected intraperitoneaUy with each virus-serum mixture--or virus dilution. The amount injected was 0.02 ml. per animal. The mice were examined daily for 2 weeks. In some instances when the amount of serum available was small the lowest dilution tested was 1:5.
Results.--Neutralization Tests.--Convalescent serum specimens from 18 patients in the
Worcester group were tested for the presence of neutralizing antibodies. In 9 cases no neutralizing antibody could be detected, while in 9 others it was demonstrated. Acute and convalescent serum specimens from each patient showing a positive result in the screening procedure were tested simultaneously in an effort to demonstrate a significant rise in antibody titer during the course of the patient's illness. In most instances the results were clear cut; if antibody could be demonstrated in the convalescent serum specimen an essentially equivalent titer could be demonstrated in the acute specimen. In only one case was it possible to show any rise in antibody level (Table III) . When late convalescent serum specimens were available these were tested as well, and the results obtained were entirely similar to those described above.
VIRAL AGENT FROM NON-PARALYTIC POLIOMYELITIS
Of the two patients from whom a virus was isolated, one (Powers) showed neutralizing antibodies against her own agent in all 3 serum specimens. The early convalescent serum specimen showed slightly greater neutralizing effect than either the acute or late convalescent one. The other (Matulaitis), had no demonstrable neutralizing antibodies in either the acute or convalescent phase serum specimen against the virus isolated from Powers (Table III) .
The incidence of neutralizing antibody to the Powers agent in adults, normal or with other disease, was investigated. Of surgical cases from a clinic serving a wide area 14 out of 20 showed neutralizing antibody; of cases of multiple sclerosis 6 out of 7, and of laboratory personnel 3 out of 7 (one with history of "non-paralytic poliomyelitis") neutralized the virus. This control group totalled 23 positive out of 34 tested. Through the courtesy of Dr. Enders and Dr. Weller paired sera from 3 cases of epidemic pleurodynla were made available. The first case (McGoff) showed some possible rise in antibody titer against approximately 700 LDs0 of virus. The second case (McLaughlin) had no demonstrable antibodies in the uudiluted acute serum specimen, but the convalescent serum gave complete neutralization even when diluted 1:100 and against the same virus challenge dose. Unequivocal neutralization could not be demonstrated in either the acute or convalescent serum (diluted 1:10) of the third case (Koch) tested (Table IV) .
Specific antisera against certain neurotropic viruses (other than members of the Coxsackie group) have been tested for their ability to neutralize the agent. The antisera tested included Mengo, Columbia SK, and GD VII. The results have been uniformly negative as demonstrated by the protocol given in Table  V .
The possible serological relationships between the agent isolated from Powers and various members of the Coxssckie group of viruses were investigated by means of the neutralization, complement fixation, and cross-immunity tests. The results are recorded in Table VI . No neutralization was demonstrated by any antiserum except the Powers specimen. This antiserum g~ve complete neutralization in a dilution of 1:100 against the homologous virus.
These five antisera just mentioned were tested for their ability to neutralize the Connecticut 5 virus. Here again the results were unequivocal (Table VII) . A definite neutralizing effect was exerted by the DeMole antiserum and by both Connecticut 5 antisera. The Powers antiserum, Ohio R antiserum, and the normal mouse serum failed to neutralize. Thus once more we were unable to t Dr. Melnick kindly tested our Powers and Connecticut 5 antisera against his Easton and Connecticut 5 virus strains. Neither serum gave any protection against the Easton strain. The Connecticut 5 virus was neutralized by the homologous antiserum, but not by the Powers antiserum.
A number of mice apparently protected by serum antibodies against ordinarily lethal challenge doses of virus were sacrificed at the end of the experiment for pathological examination. In general the correlation between obvious illness and pathological findings was good; i.e., mice that survived and showed no sign of sickness presented little or no pathological evidence of infection. OccasionaUy healed calcified lesions were noted in the myocardium, or in the adipose tissue, or in both. Conversely, an occasional mouse thought to show some sign of illness at the end of the observation period failed to show any anatomical evidence of infection at autopsy. Mice that developed signs of the disease after inoculation of serum-virus mixtures showed typical lesions. (Table IX) . Of the remaining Worcester patients, two were negative, one reacted with normal tissue, and 15 showed a constant level of complement-fixing antibody when acute phase sera and one or two convalescent sera were compared. A control group of human sera showed a high incidence of complement-fixing antibody.
Cross-Immunity Tests.mA group of female mice was immunized against the Powers virus by a series of intramuscular injections as previously described, and bred. Other groups were similarly immunized against the Connecticut 5 All sera from a given patient were tested simultaneously. * Reciprocal of initial serum dilution giving a 3-{-reaction.
Clinical diagnosis epidemic pleurodynia. virus and the DeMole virus. In general the last dose of vaccine was admiuistered 1 to 2 weeks before parturition. No obvious illness or pathological evidence suggesting the transmi~ion of infection in utero from mother to young was Obtained. One to 2 day old litters from each group were then challenged by the intraperitoneal inoculation of the homologous virus strains, and of three heterologons strains as well. Control litters of normal mice were injected also in order to confirm the potency of each inoculum which was actually titrated only in the case of the Powers and Connecticut 5 viruses.
The results are shown in Table X . Litters resisted a large challenge inoculum of the homologous agent, but succumbed to a smaller one of each of the heterologous strains except in the case of the DeMoie and Connecticut 5 strains. The serological relationship of the DeMole virus to the other strains is discussed in another paper describing the isolation of that agent (12) . No evidence of immunological relationship between the Powers agent and the three Coxsaekie strains was obtained by this method.
DISCUSSION
The pioneer studies of Dalldoff (1) and of Melnick (2-4) have led to the definition of a new group of viral agents whose most characteristic biological properties are: first, host range limited to suckling mice, hamsters, and certain monkeys and second, the apparently uniform production of myositis (10) . Individual strains of this group (generally known as Coxsackie or C group of viruses) have been isolated from a number of individuals, and in addition from extrahuman sources such as sewage and flies. The evidence that they may cause clinical disease in man is strong. The agent described in the present communication bears certain resemblances to this group of viruses. Suckling mice (and perhaps voles) are the only susceptible species noted so far. Some of the pathological findings resemble those described in connection with the Coxsackie group of viruses. On the other hand, the sharper age limitation (as compared to Dalldorf's findings (1)) and our consistent failure to recognize myositis suggest the possibility that this agent may be one not too closely related to those previously described. The serological evidence at hand tends to bear this out. These findings, pathological and serological, appear to justify a brief description.
There appears to be no doubt that our agent is of human rather than murine origin. On the positive side is the fact that it has been isolated twice from the same stool specimen several months apart. Further evidence stems from our inability to isolate a similar agent during the course of many mouse passages with negative material. Were such an agent latent in our mice one would have expected to pick it up in the course of such manipulations.
That the agent had some etiological connection with the clinical syndrome of patient Powers is probable since a clear cut rise in complement-fixing antibody and a slight rise in neutralizing antibody during the course of the illness were shown. The presence of one or the other or both antibodies in the remaining Worcester patients may have no relationship to the disease under investigation since a group of control sera revealed an even higher incidence of both antibodies. A correlation between neutralizing and complement-fixing antibodies was observed only in those cases in which both antibodies rose. There is thus neither serological nor epidemiological evidence that the Worcester cases were caused by any single agent.
In addition two paired (acute and convalescent phase) sera, kindly made available to us by Dr. Enders and Dr. WeUer, showed a rise in complementfixing antibody and at least one pair a rise in neutralizing antibody. In these cases the clinical diagnosis was epidemic pleurodynia.
Me]nick (4) has emphasized the rapidly accumulating evidence that infections with strains of the Coxsackie group of viruses have occurred in widespread areas of this country. In connection with this it is interesting to note that in several instances we have been able to demonstrate antibodies versus the Powers strain in the sera of individuals not known to have suffered from illnesses resembling those reported by Curnen el al. (3) and other investigators. One exception to this was normal adult K, who gave a history of having had nonparalytic poliomyelitis several years previously.
The relationship of the Powers agent to the Coxsackie group of viruses remains to be determined. The pathological similarities and differences have been mentioned and are the subject of a detailed discussion in the accompanying paper. The serological evidence at hand so far suggests no relationship to the Connecticut 5, Ohio R, and High Point strains of Melnick, and crossimmunity tests bear this out. The significance of a rise in neutralizing antibodies in one case, and of complement-fixing antibodies in two cases of epidemic pleurodynia is not dear. The question of a possible serological relationship between the Powers and DeMole and DeMole and Connecticut 5 agents is also considered in another paper (12) . It is obvious that further studies are required in order to clarify the etiological and serological relationships of these various viruses. SUMMARY 1. A viral agent, Powers, causing myocarditis, adipositis, pancreatitis, hepatitis, and encephalomyelitis but not myositis in suckling mice 1 to 2 days old has been isolated from the stool of a patient in whom the clinical diagnosis was t'non-paralytic poliomyelitis." 2. Serological evidence linking the virus to the clinical disease observed was clear only in the case of "non-paralytic poliomyelitis" from which it was isolated.
3. The possible relation of this agent to the Coxsackie group of viruses is discussed. No serological relationship with the Connecticut 5, Ohio R, and High Point strains was demonstrated. 4 . A second virus, Matulaitis, has been isolated from a concurrent case of "non-paralytic poliomyelitis" in the same area. Lesions produced in infant mice by the two agents show certain differences.
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